SERA PROGNOSTICS, INC. Intangible Assets, Gross (Excluding Goodwill)
SERA PROGNOSTICS, INC. (SERA) had Intangible Assets, Gross (Excluding Goodwill) of $1.08 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:IntangibleAssetsGrossExcludingGoodwill · last filed 2026-08-12
- 2026-06-30: Intangible Assets, Gross (Excluding Goodwill) $1.08M.
- 2026-03-31: Intangible Assets, Gross (Excluding Goodwill) $1.04M.
- 2025-12-31: Intangible Assets, Gross (Excluding Goodwill) $1.04M.
- 2025-09-30: Intangible Assets, Gross (Excluding Goodwill) $1.04M.
| Period end | Intangible Assets, Gross (Excluding Goodwill) |
|---|---|
| 2026-06-30 | $1.08M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.04M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.04M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $1.04M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.04M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.04M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $1.04M 10-K · filed 2026-03-18 |
| 2024-09-30 | $992.00K 10-Q · filed 2024-11-06 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |